Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: An early marker for acute myocardial infarction

Clinical Biochemistry

Volumn 32, Issue 3, 1999, Pages 229-231

  Key, Göran ^a   Schreiber, Andrea ^a,e   Feldbrügge, Rainer ^a   McNeil, Calum J ^b   Jørgensen, Poul ^c   Pelsers, Maurice M A L ^d   Glatz, Jan F C ^d   Spener, Friedrich ^e  

^a ICB Institut fur Chemo und Biosensorik GmbH   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN;

ACUTE HEART INFARCTION; AMPEROMETRY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HUMAN; IMMUNOSENSOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION;

BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; CARRIER PROTEINS; ELECTROCHEMISTRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FATTY ACID-BINDING PROTEINS; HUMANS; MYELIN P2 PROTEIN; MYOCARDIAL INFARCTION; NEOPLASM PROTEINS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEINS;

EID: 0032976156     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00108-8     Document Type: Article

References (10)

1. Kleine A.H., Glatz J.F.C., Van Nieuwenhoven F.A., Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 116:1992;155-162.
2. Glatz J.F.C., Kleine A.H., Van Nieuwenhoven F.A., et al. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarction size in humans. Br Heart J. 71:1994;135-140.
3. Glatz JFC, Haastrup B, Hermens WT, et al. Fatty acid-binding protein and the early detection of acute myocardial infarction: the EUROCARDI multicenter trial. Circulation 1997; 96(suppl): I-215.
4. Ishii J., Wang J.H., Naruse H., et al. Serum concentrations of myoglobin vs heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem. 43:1997;1372-1378.
5. Schreiber A., Feldbrügge R., Key G., Glatz J.F.C., Spener F. An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction. Biosens Bioelectron. 12:1997;1131-1137.
6. Wodzig K.W.H., Pelsers M.M.A.L., van der Vusse G.J., Roos W., Glatz J.F.C. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem. 34:1997;263-268.
7. Roos W., Eymann E., Symannek M., Duppenthaler J., Wodzig K.W.H., Pelsers M., Glatz J.F.C. Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods. 183:1995;149-153.
8. DeRiemer L.H., Meares C.F. Synthesis of mono- and dinucleotide photoaffinity probes of ribonucleic acid polymerase. Biochemistry. 20:1981;1606-1612.
9. Bland J.M., Altman G.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. i:1986;307-310.
10. Wodzig K.W.H., Kragten J.A., Hermens W.T., Glatz J.F.C., van Dieijen-Visser M.P. Estimation of myocardial infarct size from myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem. 35:1997;191-198.